Results 121 to 130 of about 59,745 (273)

Marked Impact of Regulatory Bans on Formaldehyde and Formaldehyde‐Releaser‐Induced Allergic Contact Dermatitis: A Retrospective Cohort Study (1996–2024) From Turkey

open access: yesContact Dermatitis, EarlyView.
The overall prevalence of sensitization to FA/FRs was 1.9% (48/2592). ACD was diagnosed in 37.5% (18/48), comprising non‐occupational ACD (83.3%) and occupational ACD (16.7%). FA 1%–2% aq. failed to detect FR sensitisation in 31.9% (n = 15/47) and FR‐induced ACD in 35.3% (n = 6/17) of patients.
Esen Özkaya   +2 more
wiley   +1 more source

TIM-4 Regulates Allergic Airway Inflammation and Mast Cell Activation by Binding to CD300b

open access: yesJournal of Asthma and Allergy
Yuki Tanabe,1,2 Fumitaka Kamachi,1 Jun Ito,2 Norihiro Harada,2 Sonoko Harada,2,3 Fumihiko Makino,2 Yoshiyuki Abe,4 Nobuhiro Nakano,3 Kumi Izawa,3 Francois Niyonsaba,3 Chiharu Nishiyama,5 Jiro Kitaura,3 Ko Okumura,1,3 Kazuhisa Takahashi,2 Hisaya Akiba,1 ...
Tanabe Y   +15 more
doaj  

Real‐Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study

open access: yesContact Dermatitis, EarlyView.
From January 2024 to May 2025, 207 patients (68.6% females) affected by CHE were enrolled to be clinically and etiologically investigated using a case report form specifically developed. The accurate workup led to clinical and etiological classification of CHE in about 80% of patients, allowing tailored treatment strategies. ABSTRACT Background Chronic
Rosella Gallo   +21 more
wiley   +1 more source

Perinatal Exposures Are Related to Atopic Symptom Development in Early Childhood

open access: yes
Clinical &Experimental Allergy, EarlyView.
Gina J. van Beveren   +9 more
wiley   +1 more source

To Avoid or Not to Avoid: Cross‐Reactivity Between Fragrance and Common Botanicals

open access: yesContact Dermatitis, EarlyView.
Among 356 fragrance‐allergic patients patch tested from 2020–2024, no clinically meaningful cross‐reactivity (> 10%) was observed between fragrance allergens and common non‐essential oil botanicals. These findings suggest fragrance‐allergic patients do not need to avoid botanicals such as aloe, coconut oil, or shea butter in fragrance‐free products ...
Sarah Karels   +5 more
wiley   +1 more source

Variants in Genes Encoding Innate Lymphoid Cells Type 2 Surface Markers Affecting Asthma and Atopy Pathologies

open access: yes
Clinical &Experimental Allergy, EarlyView.
Raphael Chagas Silva   +13 more
wiley   +1 more source

Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema

open access: yesContact Dermatitis, EarlyView.
Patient‐reported outcomes are an important complement to physician‐assessed clinical outcome measures in Chronic Hand Eczema. In a pooled analysis of two randomised, controlled trials, twice‐daily treatment with delgocitinib cream 20 mg/g significantly improved the health‐related quality of life of patients with moderate to severe Chronic Hand Eczema ...
Andrea Bauer   +7 more
wiley   +1 more source

House Dust Mite Sensitisation Effectively Differentiates Atopy From Non‐Atopy in the Tropical Environment of Southeast Asia

open access: yes
Clinical &Experimental Allergy, EarlyView.
Yang Yie Sio   +4 more
wiley   +1 more source

Healthy Diet Intervention for Treating Atopic Dermatitis: A Pilot Randomised Controlled Trial

open access: yes
Clinical &Experimental Allergy, EarlyView.
Jun Jie Lim   +5 more
wiley   +1 more source

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

open access: yesContact Dermatitis, EarlyView.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy